BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 12607658)

  • 1. Clinical impact of drug-eluting stents in changing referral practices for coronary surgical revascularization in a tertiary care center.
    Ferreira AC; Peter AA; Salerno TA; Bolooki H; de Marchena E
    Ann Thorac Surg; 2003 Feb; 75(2):485-9. PubMed ID: 12607658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of drug-eluting stents and coronary artery bypass surgery for the treatment of multivessel coronary disease: three-year follow-up results from a single institution.
    Li Y; Zheng Z; Xu B; Zhang S; Li W; Gao R; Hu S
    Circulation; 2009 Apr; 119(15):2040-50. PubMed ID: 19349321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proximal left anterior descending coronary artery revascularization with drug-eluting stents.
    Guardado JH; Moreno R; Costa J; Perez-Viscayno MJ; Segura L; Alfonso F; Hernández R; Escaned J; Bañuelos C; Macaya C
    Arq Bras Cardiol; 2007 Feb; 88(2):159-66. PubMed ID: 17384832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expert consensus (SBC/SBHCI) on the use of drug-eluting stents: recommendations of the Brazilian society of interventional cardiology/ Brazilian society of cardiology for the Brazilian public single healthcare system.
    Lima VC; Mattos LA; Caramori PR; Perin MA; Mangione JA; Machado BM; Coelho WM; Bueno RR
    Arq Bras Cardiol; 2006 Oct; 87(4):e162-7. PubMed ID: 17128305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sirolimus-eluting vs uncoated stents for prevention of restenosis in small coronary arteries: a randomized trial.
    Ardissino D; Cavallini C; Bramucci E; Indolfi C; Marzocchi A; Manari A; Angeloni G; Carosio G; Bonizzoni E; Colusso S; Repetto M; Merlini PA;
    JAMA; 2004 Dec; 292(22):2727-34. PubMed ID: 15585732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Drug-eluting stents in patients with left main coronary lesions who are not candidates for surgical revascularization].
    Lozano I; Herrera C; Morís C; Gómez-Hospital JA; Rondán J; Iráculis E; Martín M; Cequier A; Suárez E; Esplugas E
    Rev Esp Cardiol; 2005 Feb; 58(2):145-52. PubMed ID: 15743560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of left anterior descending coronary artery disease with sirolimus-eluting stents.
    Sawhney N; Moses JW; Leon MB; Kuntz RE; Popma JJ; Bachinsky W; Bass T; DeMaio S; Fry E; Holmes DR; Teirstein PS
    Circulation; 2004 Jul; 110(4):374-9. PubMed ID: 15249503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of sex on clinical and angiographic outcomes among patients undergoing revascularization with drug-eluting stents.
    Stefanini GG; Kalesan B; Pilgrim T; Räber L; Onuma Y; Silber S; Serruys PW; Meier B; Jüni P; Windecker S
    JACC Cardiovasc Interv; 2012 Mar; 5(3):301-10. PubMed ID: 22440496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions: the REALITY trial: a randomized controlled trial.
    Morice MC; Colombo A; Meier B; Serruys P; Tamburino C; Guagliumi G; Sousa E; Stoll HP;
    JAMA; 2006 Feb; 295(8):895-904. PubMed ID: 16493102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indications of coronary angioplasty and stenting in 2003: what is left to surgery?
    Poyen V; Silvestri M; Labrunie P; Valeix B
    J Cardiovasc Surg (Torino); 2003 Jun; 44(3):307-12. PubMed ID: 12832982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Favorable long-term outcome after drug-eluting stent implantation in nonbifurcation lesions that involve unprotected left main coronary artery: a multicenter registry.
    Chieffo A; Park SJ; Valgimigli M; Kim YH; Daemen J; Sheiban I; Truffa A; Montorfano M; Airoldi F; Sangiorgi G; Carlino M; Michev I; Lee CW; Hong MK; Park SW; Moretti C; Bonizzoni E; Rogacka R; Serruys PW; Colombo A
    Circulation; 2007 Jul; 116(2):158-62. PubMed ID: 17576862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Percutaneous coronary angioplasty in diabetic patients: new prospects with drug-eluting stents].
    Warzee F; Legrand V; Scheen AJ
    Rev Med Liege; 2004 Dec; 59(12):711-6. PubMed ID: 15658058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of distal/bifurcation left main restenosis after drug eluting stents implantation: single center experience.
    Rigatelli G; Cardaioli P; Dell'Avvocata F; Giordan M; Vassilev D; Fraccaro C; Roncon L; Faggian G
    Cardiovasc Revasc Med; 2014 Mar; 15(2):76-9. PubMed ID: 24560299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initial clinical impact of drug eluting stents on coronary artery bypass graft surgery.
    Kanemitsu S; Tanaka K; Tanaka J; Suzuki H; Kinoshita T
    Interact Cardiovasc Thorac Surg; 2007 Oct; 6(5):632-5. PubMed ID: 17670720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial.
    Kastrati A; Mehilli J; von Beckerath N; Dibra A; Hausleiter J; Pache J; Schühlen H; Schmitt C; Dirschinger J; Schömig A;
    JAMA; 2005 Jan; 293(2):165-71. PubMed ID: 15644543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-eluting stents versus arterial myocardial revascularization in patients with diabetes mellitus.
    Ben-Gal Y; Mohr R; Uretzky G; Medalion B; Hendler A; Hansson N; Herz I; Moshkovitz Y
    J Thorac Cardiovasc Surg; 2006 Oct; 132(4):861-6. PubMed ID: 17000298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Temporal trends in the use of drug-eluting stents in German clinical practice].
    Klein B; Zahn R; Heer T; Hochadel M; Tebbe U; Darius H; Kerber S; Schumacher B; Grube E; Hauptmann KE; Glunz HG; Senges J; Zeymer U
    Herz; 2008 Sep; 33(6):450-4. PubMed ID: 19156380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transition from bare metal to drug eluting stenting in contemporary US practice: effect on incidence and predictors of clinically driven target lesion revascularization.
    Jonas M; Resnic FS; Levin AD; Arora N; Rogers CD
    Catheter Cardiovasc Interv; 2007 Aug; 70(2):175-83. PubMed ID: 17630659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of drug-eluting balloons alone or in combination with drug-eluting stents in the treatment of de novo diffuse coronary disease.
    Costopoulos C; Latib A; Naganuma T; Sticchi A; Figini F; Basavarajaiah S; Carlino M; Chieffo A; Montorfano M; Naim C; Kawaguchi M; Giannini F; Colombo A
    JACC Cardiovasc Interv; 2013 Nov; 6(11):1153-9. PubMed ID: 24262615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two-year clinical follow up of coronary drug-eluting stent in patients at high risk for coronary restenosis.
    Azzarelli S; Amico F; Galassi AR; Giacoppo M; Argentino V; Fiscella A
    J Invasive Cardiol; 2008 Feb; 20(2):62-6. PubMed ID: 18252969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.